121 related articles for article (PubMed ID: 6468379)
21. Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers.
Parker MA; King V; Howard KP
Biochim Biophys Acta; 2001 Oct; 1514(2):206-16. PubMed ID: 11557021
[TBL] [Abstract][Full Text] [Related]
22. The anionic phospholipid-mediated membrane interaction of the anti-cancer drug doxorubicin is enhanced by phosphatidylethanolamine compared to other zwitterionic phospholipids.
Speelmans G; Staffhorst RWHM ; de Kruijff B
Biochemistry; 1997 Jul; 36(28):8657-62. PubMed ID: 9214313
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of phosphatidylglycerol, phosphatidylethanolamine, and cardiolipin of Bacillus stearothermophilus.
Card GL
J Bacteriol; 1973 Jun; 114(3):1125-37. PubMed ID: 4712568
[TBL] [Abstract][Full Text] [Related]
24. A comparative model membrane study on structural effects of membrane-active positively charged anti-tumor drugs.
Nicolay K; Sautereau AM; Tocanne JF; Brasseur R; Huart P; Ruysschaert JM; de Kruijff B
Biochim Biophys Acta; 1988 May; 940(2):197-208. PubMed ID: 3163502
[TBL] [Abstract][Full Text] [Related]
25. Adriamycin-iron catalysed phospholipid peroxidation: a reaction not involving reduced adriamycin or hydroxyl radicals.
Gutteridge JM
Biochem Pharmacol; 1983 Jun; 32(12):1949-52. PubMed ID: 6309187
[No Abstract] [Full Text] [Related]
26. Physical and chemical modifications of adriamycin:iron complex by phospholipid bilayers.
Samuni A; Chong PL; Barenholz Y; Thompson TE
Cancer Res; 1986 Feb; 46(2):594-9. PubMed ID: 3940630
[TBL] [Abstract][Full Text] [Related]
27. Headgroup interactions in mixed phospholipid bilayers.
Sixl F; Watts A
Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1613-5. PubMed ID: 6572925
[TBL] [Abstract][Full Text] [Related]
28. Fe3+ binding to liposomes of different phospholipid composition.
Tadolini B; Motta P; Rossi CA
Biochem Mol Biol Int; 1993 Feb; 29(2):299-305. PubMed ID: 8495214
[TBL] [Abstract][Full Text] [Related]
29. Effect of lipid bilayer properties on the photocycle of green proteorhodopsin.
Lindholm L; Ariöz C; Jawurek M; Liebau J; Mäler L; Wieslander Å; von Ballmoos C; Barth A
Biochim Biophys Acta; 2015 Aug; 1847(8):698-708. PubMed ID: 25922153
[TBL] [Abstract][Full Text] [Related]
30. dl-N,N'-dicarboxamidomethyl-N,N'-dicarboxymethyl-1,2-diaminopropane (ICRF-198) and d-1,2-bis(3,5-dioxopiperazine-1-yl)propane (ICRF-187) inhibition of Fe3+ reduction, lipid peroxidation, and CaATPase inactivation in heart microsomes exposed to adriamycin.
Vile GF; Winterbourn CC
Cancer Res; 1990 Apr; 50(8):2307-10. PubMed ID: 2156615
[TBL] [Abstract][Full Text] [Related]
31. An essential requirement of cardiolipin for mitochondrial carnitine acylcarnitine translocase activity. Lipid requirement of carnitine acylcarnitine translocase.
Noël H; Pande SV
Eur J Biochem; 1986 Feb; 155(1):99-102. PubMed ID: 3948883
[TBL] [Abstract][Full Text] [Related]
32. Inhibition and inactivation of NADH-cytochrome c reductase activity of bovine heart submitochondrial particles by the iron(III)-adriamycin complex.
Hasinoff BB
Biochem J; 1990 Feb; 265(3):865-70. PubMed ID: 2306220
[TBL] [Abstract][Full Text] [Related]
33. Tryptophan fluorescence study on the interaction of the signal peptide of the Escherichia coli outer membrane protein PhoE with model membranes.
Killian JA; Keller RC; Struyvé M; de Kroon AI; Tommassen J; de Kruijff B
Biochemistry; 1990 Sep; 29(35):8131-7. PubMed ID: 2175648
[TBL] [Abstract][Full Text] [Related]
34. Interaction between ferric ions, phospholipid hydroperoxides, and the lipid phosphate moiety at physiological pH.
Morrill GA; Kostellow A; Resnick LM; Gupta RK
Lipids; 2004 Sep; 39(9):881-9. PubMed ID: 15669764
[TBL] [Abstract][Full Text] [Related]
35. Thermal adaptation of Tetrahymena membranes with special reference to mitochondria. II. Preferential interaction of cardiolipin with specific molecular species of phospholipid.
Ohki K; Goto M; Nozawa Y
Biochim Biophys Acta; 1984 Feb; 769(3):563-70. PubMed ID: 6421321
[TBL] [Abstract][Full Text] [Related]
36. Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity.
Goormaghtigh E; Huart P; Praet M; Brasseur R; Ruysschaert JM
Biophys Chem; 1990 Apr; 35(2-3):247-57. PubMed ID: 2204444
[TBL] [Abstract][Full Text] [Related]
37. Evidence of a covalent linkage in the adriamycin-cardiolipin complex induced by adriamycin-mediated electron transport.
Goormaghtigh E; Ruysschaert JM
Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):149-52. PubMed ID: 6316434
[TBL] [Abstract][Full Text] [Related]
38. The interaction of adriamycin with small unilamellar vesicle liposomes. A fluorescence study.
Karczmar GS; Tritton TR
Biochim Biophys Acta; 1979 Nov; 557(2):306-19. PubMed ID: 583025
[TBL] [Abstract][Full Text] [Related]
39. The iron(III)-adriamycin complex inhibits cytochrome c oxidase before its inactivation.
Hasinoff BB; Davey JP
Biochem J; 1988 Mar; 250(3):827-34. PubMed ID: 2839147
[TBL] [Abstract][Full Text] [Related]
40. Lipidic particles.
Verkleij AJ; de Kruijff B; van Echteld CJ; Gerritsen WJ; Mombers C; Noordam PC; Leunissen-Bijvelt J; de Gier J
Acta Histochem Suppl; 1981; 23():145-9. PubMed ID: 6784158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
